Chapter 9 Novel ligands for P2 receptor subtypes in innervated tissues
- 1 January 1999
- book chapter
- Published by Elsevier
- Vol. 120, 107-117
- https://doi.org/10.1016/s0079-6123(08)63549-9
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- A Pyridoxine Cyclic Phosphate and Its 6-Azoaryl Derivative Selectively Potentiate and Antagonize Activation of P2X1 ReceptorsJournal of Medicinal Chemistry, 1998
- The interaction of diadenosine polyphosphates with P2X‐receptors in the guinea‐pig isolated vas deferensBritish Journal of Pharmacology, 1997
- Vasoconstrictor responses via P2X‐receptors are selectively antagonized by NF023 in rabbit isolated aorta and saphenous arteryBritish Journal of Pharmacology, 1997
- Design and pharmacology of selective P2‐purinoceptor antagonistsJournal of Autonomic Pharmacology, 1996
- Pharmacological and second messenger signalling selectivities of cloned P2Y receptorsJournal of Autonomic Pharmacology, 1996
- SIGNALING BY EXTRACELLULAR NUCLEOTIDESAnnual Review of Cell and Developmental Biology, 1996
- Novel competitive antagonists for P2 purinoceptorsEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Structure activity relationships for derivatives of adenosine‐5′‐triphosphate as agonists at P2 purinoceptors: Heterogeneity within P2x and P2y subtypesDrug Development Research, 1994
- Purinoceptors: Are there families of P2X and P2Y purinoceptors?Pharmacology & Therapeutics, 1994
- Is there a basis for distinguishing two types of P2-purinoceptor?General Pharmacology: The Vascular System, 1985